Pirlindole Hydrochloride is a selective and reversible monoamine oxidase A inhibitor used in the treatment of major depressive disorder. By preventing the breakdown of norepinephrine and various catecholamines,… Read more
Pirlindole Hydrochloride is a selective and reversible monoamine oxidase A inhibitor used in the treatment of major depressive disorder. By preventing the breakdown of norepinephrine and various catecholamines, this antidepressant helps regulate neuromodulator levels to alleviate depressive symptoms. To ensure accurate pharmaceutical analysis, laboratories rely on high-quality reference standards of Pirlindole Hydrochloride, including its related impurities and metabolites. These compounds are essential for impurity profiling, method validation, and rigorous quality control within pharmaceutical manufacturing and research. Utilizing stable isotope labelled versions of the drug allows for precise quantification in complex biological matrices, facilitating reliable pharmacokinetic studies. The availability of these reference materials supports the development and regulatory compliance of pharmaceutical products by ensuring that analytical methods can effectively identify and monitor related substances throughout the drug lifecycle.